Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstruc...

Josep Darbà, Gabriela Ramírez, Juan L García-Rivero, Sagrario Mayoralas-Alises, José-Francisco Pascual-Lledó, Diego Vargas, Adi Bijedic
  • ClinicoEconomics and Outcomes Research, February 2017, Dove Medical Press
  • DOI: 10.2147/ceor.s125301

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Sagrario Mayoralas Alises